Fat grafting has emerged as an important tool in the armamentarium of plastic surgeons. Its applications in aesthetic and reconstructive surgery continue to expand. However, its limitations (such as inconsistent survival) remain problematic. Recent research efforts have focused on tacking these issues with the use of platelet rich plasma, hypoxic preconditioning, hyperbaric oxygen, and the tissue engineering of scaffolds. In the future, as these laboratory discoveries are translated to clinical application, the beneficial uses of fat grafting will continue to increase.
Fat grafting is an important tool in the armamentarium of plastic surgeons, with use in a variety of reconstructive and cosmetic settings. Its applications for tissue repair and reconstruction have broadened as our understanding of the process has improved leading to greater acceptance in the plastic surgery community. However, fat graft absorption and inconsistent survival remain problematic often resulting in additional operative procedures as well as complications such as fat necrosis and oil cysts. As a result, recent research efforts have focused at methods to improve retention of transplanted fat. A number of promising approaches have been described in preclinical and clinical series and will be the subject of this review (Table 1) .
Platelet Rich Plasma (PRP)
Platelet rich plasma (PRP) has emerged as a promising modality to improve fat graft take. PRP is a concentrated mixture of platelets in plasma, obtained by centrifugation of whole blood. The alpha granules of platelets have growth factors that promote wound healing by promoting angiogenesis and production of extracellular matrix products. These growth factors include platelet-derived growth factor, transforming growth factor-b (TGF-B), vascular endothelial growth factor (VEGF), epithelial growth factor (EGF), insulin-like growth factor, fibroblast growth factor, and platelet-derived angiogenesis factor.
Because injected fat survives at its transplanted site by imbibition and neovascularization, a number of researchers have hypothesized that injection of PRP at the time of fat grafting will increase fat graft take. This hypothesis has been tested in a number of animal studies with mixed results due, among other things, to inconsistent methodologies and animal models. However, in general, the majority of animal studies have shown that PRP has beneficial effects resulting in improved fat graft survival, angiogenesis, decreased inflammation, and decreased graft fibrosis. For example, Nakamaura et al implanted rat inguinal fat prepared with PRP into a dorsal subcutaneous pocket of recipient mice and showed that compared to control animals (fat grafted without PRP), the addition of PRP significantly increased fat retention grossly. Histology confirmed this and showed increased granulation tissue and capillary formation. 1 Pires Fraga injected PRP enriched fat grafts into the ears of rabbits and demonstrated increased number of viable adipocytes and blood vessels in the PRP group and increased necrosis and fibrosis in the control group. 2 Using a lip fat grafting model in rabbits, RodriguezFlores found that addition of PRP to fat grafts decreased inflammatory reactions and decreased the number of oil cysts as compared with controls that had fat grafts without PRP. 3 Similarly, using nude mice, Oh et al showed that fat grafting with PRP increased vascularity, decreased oil cysts/vacuoles, and decreased fibrosis. 4 Despite promising results in preclinical studies, there is still a relative paucity of high quality clinical studies on the effects of PRP on fat grafting. Cervelli et al performed autologous fat grafting for facial contour restoration and observed 70% retention of fat with PRP-enriched fat grafting compared to 31% with fat grafting alone. 5 On the other hand, Salgarello et al and Fontdevila et al showed no gain in volume retention with addition of PRP. Similarly, in a retrospective study of breast fat grafting in 42 patients, of which 17 had fat grafts with PRP, Salgarello et al did no observe any benefit of PRP when analyzing outcomes by clinical assessment, incidence of fat necrosis on breast ultrasound, or the need for additional fat grafting procedures. 6 Fontdevila et al performed a double blind clinical trial in which fat grafting was used for human immunodeficiency virus (HIV) facial lipoatrophy. Patients were randomized to fat injection only and fat with PRP group. Results were analyzed at 2 and 12 months by computed tomographic scans. Volume measurements showed no statistical difference in the volume of fat retained. 7 However, Gentile et al demonstrated a benefit of PRP with fat grafting in breast reconstruction. They performed fat grafting alone in 50 patients and fat grafting + PRP in another 50. Results were analyzed by analysis of photographs and magnetic resonance imaging (MRI). At one-year follow up they observed 69% maintenance of contour and volume in the PRP group vs 39% in the fat graft only group. 8 Cervelli et al studied the effect of various concentrations of PRP in fat injections. They observed increasing maintenance of contour restoration with increasing PRP concentrations or 0.2 to 0.5 mL per mL of fat. The volume retention was 30% for controls, 50% for 0.2 mL PRP, 62% for 0.3% PRP, and 70% for 0.4% or 0.5% PRP. 9 However, it is not exactly clear how the results were analyzed and it appears that outcomes were assessed by clinical evaluation by physician and patient. PRP is therefore emerging as a very promising modality in enhancing fat graft retention and may be an important adjunct in clinical fat grafting in the future.
Stromal Vascular Fraction (SVF)
Stromal vascular fraction (SVF) is the extracellular matrix products and cells that remain after adipose tissues and fluids are removed from the liposuction aspirate ( Figure 1 ). The SVF is a relatively small proportion of the entire lipoaspirate but is highly enriched in adipose derived stem cells (ASCs) and growth factors. ASCs are mesenchymal stem cells found in fat tissue and can differentiate into a variety of cell types including fat, bone, and cartilage. Fat is the richest and most abundant source of stem cells, yielding 5000 ASCs per gram 45 which is the likely mechanism of enhanced fat survival. The data for the direct effect of PRP on adipogenesis is conflicting, as some studies show increased while others show decreased adipogenesis. 46, 47 Improved fat graft survival, increased angiogenesis, decreased inflammation and decreased graft fibrosis. [1] [2] [3] [4] 13 Mixed results, with some studies showing increased fat retention with PRP while others showing no benefit. [5] [6] [7] [8] [9] PRP is findings increasing applications due to its tissue regeneration effects. More research is needed to prove the efficacy and safety of PRP in clinical fat grafting. Surgical techniques (harvest and delivery methods) and optimal dosages need to be determined.
SVF
ASCs secrete cytokines and angiogenic growth factors, which are the likely cause of the increased fat survival observed. 45 Increased fat retention and angiogenesis. 13 Increased fat volume retention with cell-assisted lipotransfer. 11, 12 More research is needed to prove the efficacy and safety of PRP in clinical fat grafting. Surgical techniques (harvest and delivery methods) and optimal dosages need to be determined.
Hypoxic Preconditioning
Increased ASC viability and expression of angiogenic growth factors. [17] [18] [19] Hypoxic preconditioned stem cells have found to increase angiogenesis, flap survival and tissue regeneration. 17, 21 No human studies have been performed on effect of hypoxic preconditioned ASCs on fat grafting.
Animal and human studies are needed to determine the efficacy and safety of hypoxic preconditioning on clinical fat grafting.
Scaffolds
Scaffolds support adipogenesis and also cause increased differentiation of pre-adipocytes. 29, 32 Scaffolds support adipogenesis, promote angiogenesis and also cause increased differentiation of pre-adipocytes to adipocytes. 29, 30, 33, 34 In breast reconstruction, external skin expansion (Brava) has been used to create an autologous vascular scaffold at the recipient site for fat grafting. 44 Viable off the shelf scaffolds that are safe, efficacious and cost effective.
of fat. ASCs have also been shown to improve wound healing by elaborating growth factors, incorporating into regenerating tissue and inhibiting inflammatory reactions. Yoshimura introduced the concept of cell-assisted lipotransfer in which isolated SVF and purified adipose tissues were re-mixed and injected together in patients undergoing cosmetic breast augmentation. Fat was obtained via liposuction and divided into two parts. Half the fat was processed to obtain SVF and mixed with the other half and injected. They performed chest circumference measurements and concluded that breast volume increased 100 to 200 mL for a mean fat injection volume of 270 mL. Cysts and microcalcifications were detected in 4 patients. 10 These results, however, were subjective and not quantified. Kolle et al performed a triple blind placebo-controlled trial to assess the survival of ASC enriched fat grafts compared to non-enriched grafts. Liposuction was performed on healthy subjects and fat obtained was used for isolation and expansion of ASCs in culture. Then 14 days later, another session of liposuction was performed at which time they reinjected fat grafts alone or fat grafts enriched with purified culture expanded ASCs. Results were analyzed via MRI and histology at 121 days post-grafting. The authors found significantly higher volume retention in the ASC enriched grafts and decreased fat necrosis but surprisingly did not find any difference in blood vessel density. 11 Koh et al in a randomized study, performed fat grafting in 10 patients with Parry-Romberg disease. 12 Five patients with injected with fat and ASC and five were injected with fat alone. Fat retention was measured with 3-dimensional (3D) camera and 3D computer tomography (CT) scan. The fat with ASC group had a 20.59% resorption rate compared to 46.81% resorption in the fat only group, which was statistically significant. Li et al studied the effects of various concentrations of ASCs on fat graft take using a mouse model. 13 Nude mice were injected with fat containing various concentrations of ASC with and without PRP at a fat to PRP ratio of 2:1. The grafts with PRP and 10 5 / mL ASCs had significantly higher fat retention and capillary formation. Thus SVF appears to hold great promise in the future to improve the clinical outcomes of fat grafting, however, additional research is needed to better understand how these procedures can be optimized. In addition, culture expansion and reinjection of ASCs in the United States is highly controversial and forbidden unless these procedures are performed as part of an institutional review board (IRB) approved study. Culture expansion of cells for reinjection is only feasible in specially certified labs and under the purview of the Food and Drug Administration (FDA). Finally, given the concerns over potential interaction of stem cells and cancer cells it is prudent to avoid injection of purified stem cells in cancer survivors until further information is available.
Hypoxic Preconditioning
Increasing the local oxygen supply or decreasing the harmful effects of hypoxia have also been an area of research for improving fat graft take. One avenue of research is the concept of hypoxic preconditioning in which either the tissues to be transferred or the recipient site are treated with brief periods of hypoxia using a tourniquet. This concept is based on previous studies demonstrating that hypoxic preconditioning increases random flap survival, increases expression of angiogenic growth factors such as vascular endothelial growth factor, and decreases tissue hypoxia. 14, 15 Preconditioning can even be performed at a remote site suggesting that circulating factors may contribute to this phenomenon. 16 Recent studies have applied hypoxic preconditioning to fat graft and ASC transfer and several groups have shown improvement in ASC survival by exposure to brief periods of hypoxia. For example, Rehman et al demonstrated that culturing ASCs in hypoxic conditions results in significantly increased expression of angiogenic growth factors including VEGF and TGF-B. 17 Co-culture of hypoxic ASCs with endothelial cells markedly decreased endothelial cell apoptosis and improved ischemic hind limb perfusion when injected into nude mice. Stubbs et al demonstrated that hypoxic preconditioning increased ASC viability, decreased apoptosis, and reduced cell injury. 18 Furthermore, preconditioned cells had increased levels of hypoxia-inducible factor-1a and VEGF. Similarly, Efimenko et al found that hypoxia increased isolated mouse ASCs gene expression of VEGF and decreased expression of anti-angiogenic factors. 19 Interestingly, these authors found that the beneficial effects of hypoxia decreased with aging. This finding is consistent with previous studies demonstrating decreased proliferative potential of aged ASCs and bone marrow derived mesenchymal stem cells (MSCs) suggesting that aged stem cells may have less therapeutic benefit. 20 Finally, Oh et al co-transplanted hypoxia preconditioned ASCs with neural stem cells in a rat spinal cord injury model and found that this strategy enhanced the survival of co-transplanted neural stem cells and increased the expression of engineered genes. 21 Taken together, these studies suggest that, hypoxic preconditioning appears to be a promising strategy to improve the therapeutic efficacy of stem cells. However, additional work is needed to define the mechanisms and utility in clinical scenarios.
Hyperbaric Oxygen
Hyperbaric oxygen (HBO) is widely used to help improve healing in ischemic and compromised wounds. Previous studies have shown that HBO increases survival of ischemic flaps, as well as skin or muscle graft take. [22] [23] [24] Although the mechanisms regulating this response are complex, it is generally agreed that HBO promotes angiogenesis and protects against reperfusion injury. These findings have lead some investigators to hypothesize that this modality would improve fat graft survival. For example, Shoshani et al used a mouse model and HBO and showed improved histological features in grafted fat although there was no difference in volume retention. 25 Kato et al employed normobaric hyperoxygenation in mice models and showed delay in adipocyte death, increased fat survival and increased adipocyte regeneration in the hyperoxygenated mice. 26 Cherng et al studied the effect of hyperbaric oxygen on the tissue engineering of cartilage from ASCs and found increased chondrogenesis with 2.5 atmospheres absolute (ATA) HBO. 27 Oxygen could thus be a tool in the future to improve fat grafting and stem cell outcomes; however, additional study is required.
Tissue Engineering of Scaffolds
Although it is generally thought that fat graft harvest is well tolerated and that most patients have ample donor tissue, in some cases there is a paucity of adipose tissues. In addition, fat graft harvest does involve a surgical procedure which may result in donor site complications. These issues have led some researchers to investigate techniques to tissue engineer adipose tissues. The main issue in these studies has been development of viable scaffolds. The ideal characteristics of a scaffold are that it should hold the 3D structure of the tissue to be created, should be biodegradable but hold its shape till host cellular infiltration has occurred, should not elicit an immune or hyper inflammatory response, should be easy to use and should be inexpensive. The fact that their use is not mainstream indicates that an ideal scaffold has yet to be developed and thus research efforts continue.
There are two types of scaffolds: biologic and synthetic. A major problem with most scaffolds is degradation of the material by host tissue prior to complete incorporation of fat cells to give the construct structural stability. The various synthetic materials that have been used for synthetic scaffolds include polylactic acid (PLA), polyglycolic acid, polyethylene terephthalate, polylactic-co-glycolic acid, polyethylene glycol, polytetrafluoroethylene, and polyethylene. 28 These scaffolds can be impregnated with ASCs and act as carriers providing stability to the stem cells till neo-adipogenesis can occur. Experimental models have shown an increase in fat cell accumulation with the use of these scaffolds. However, the problem of these scaffolds disintegrating prior to the fat cells obtaining sufficient structural support is yet to be solved. 29 Biologic scaffolds have properties that more closely match the extracellular matrix (ECM). The ECM is a tissue framework that not only provides structural support but also directs the differentiation of stem cells to various tissue components. Biologic materials that have been used as scaffolds include collagen, gelatin, matrigel, chitosan, alginates, decellularized human placenta, and hyaluronic acids. Collagen sponges inoculated with ASCs and preadipocytes have been extensively studied in experimental models and have shown to promote adipogenesis. 30, 31 However, the collagen scaffold is disintegrated rapidly. The placenta is a rich source of human ECM components. Experimental work has shown that it can adhere to precursor cells at earlier time points and thus shows great potential as a viable scaffold material. 32, 33 An autologous matrix would in theory be the ideal scaffold material to use. Choi developed ECM powders by obtaining human adipose tissue via suction lipectomy, removal of blood and components, homogenizing, centrifuging and freeze-drying. The resulting matrix was converted to an injectable form by grounding into a powder. The ECM powder, mixed with ASCs, was injected into nude mice and demonstrated adipogenesis with well-organized tissue constructs. 34 At this time, the process is time consuming and not ready for clinical application. However, it holds great promise as a modality for tissue repair and regeneration. Further research will undoubtedly result in production of viable scaffolds and will greatly expand the applications of fat grafting in the future.
DISCUSSION
Fat grafting is now a mainstream procedure in aesthetic and reconstructive surgery. The main challenges that remain are unpredictable graft take, recipient site complications (eg, cysts, fat necrosis, calcifications), donor site complications (eg, contour abnormalities from aggressive harvest), and insufficient donor sites (children, thin patients). Current research efforts are focused at finding solutions to these problems. Of the various modalities being investigated, PRP has been the focus of the most clinical interest. PRP has been used in a number of other areas including orthopedics, 35 plastic surgery, 36 dermatology, 37 ophthalmology, 38, 39 and wound management. 40 In aesthetic surgery, PRP is used as an adjunct in facial rejuvenation procedures and in the management of alopecia. It is therefore intuitive that PRP would be investigated for improving the outcome of fat grafting. Current research indicates a beneficial effect of PRP and SVF on fat graft takes. However, there is a paucity of objective high quality research demonstrating a significant benefit of PRP and SVF in the clinical setting. As more clinical studies are performed and surgical techniques are refined, PRP and SVF may become a regular component of the future fat grafting operations.
A newer area of interest in fat grafting is its application in difficult reconstructive problems like thermal and radiation injury. Fat has been shown in some studies to improve scar contracture and the skin quality of burn scars, presumably due to the regenerative effects of ASCs. 41 Fat has also been shown to improve intractable neuropathic pain after severe burns. 42 Fat grafting for radiation induced tissue injury has also gained popularity recently as fat has been shown to improve the quality of radiated tissue. 43 
CONCLUSIONS
The last decade has ushered in great discoveries in the lab that have improved our understanding of ASCs and tissue regeneration. Fat holds great promise due to its abundance and richness of stem cell and stromal elements. Further efforts directed at improving stem cell survival and optimizing the tissue microenvironment will help translate laboratory discoveries to clinical application.
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